Landscapes / Companies
PPD Development, LP not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
2
in active trials
Trials
4 active
4 since 2021
Drugs2
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
InflaRx |
Approved in the EU | Jul 2028Phase 2 trial completes | ||
| How it works | An antibody | ||||
| Next date | Jul 2028 · Phase 2 trial completes | ||||
| Also tested for | Acute Respiratory Distress Syndrome (ARDS), ARDS and 2 more | ||||
| Open drug page | |||||
Artificial immunoglobulin |
Phase 2 | Jul 2028Phase 2 trial completes | |||
| How it works | An antibody | ||||
| Next date | Jul 2028 · Phase 2 trial completes | ||||
| Also tested for | Acute Respiratory Distress Syndrome (ARDS), ARDS and 2 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021